The Cholinergic System as a Treatment Target for Opioid Use Disorder Kevin P. JensenElise E. DeVitoMehmet Sofuoglu Leading Article 26 September 2018 Pages: 981 - 996
Ketamine for Refractory Status Epilepticus: A Systematic Review Anna RosatiSalvatore De MasiRenzo Guerrini Systematic Review 19 September 2018 Pages: 997 - 1009
Clozapine and Psychosocial Function in Schizophrenia: A Systematic Review and Meta-Analysis Andrew T. OlagunjuScott R. ClarkBernhard T. Baune Systematic Review 28 August 2018 Pages: 1011 - 1023
From LBR-101 to Fremanezumab for Migraine Marcelo E. BigalAlan M. RapoportErnesto Aycardi Review Article 11 October 2018 Pages: 1025 - 1037
Impact of Glatiramer Acetate on B Cell-Mediated Pathogenesis of Multiple Sclerosis Stefanie KuertenLeila J. JacksonTimothy L. Vollmer Review Article Open access 12 October 2018 Pages: 1039 - 1051
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects Lesley TaylorBarry GidalGilmour Morrison Original Research Article Open access 30 October 2018 Pages: 1053 - 1067
Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis Dimitrios PapadopoulosDimos-Dimitrios D. Mitsikostas Original Research Article 01 August 2018 Pages: 1069 - 1078
